Regulus Therapeutics
RGLS
#8863
Rank
ยฃ82.83 M
Marketcap
ยฃ1.26
Share price
2.58%
Change (1 day)
22.59%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -ยฃ32.07 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -ยฃ23.41 Million a decrease over its 2022 earnings that were of -ยฃ21.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ32.07 Million36.96%
2023 -ยฃ23.41 Million6.51%
2022 -ยฃ21.98 Million2.53%
2021 -ยฃ21.44 Million93.59%
2020 -ยฃ11.08 Million-15.41%
2019 -ยฃ13.1 Million-64.46%
2018 -ยฃ36.83 Million-33.26%
2017 -ยฃ55.19 Million-13.98%
2016 -ยฃ64.16 Million44.77%
2015 -ยฃ44.32 Million-1.63%
2014 -ยฃ45.05 Million203.6%
2013 -ยฃ14.84 Million8.65%
2012 -ยฃ13.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ยฃ3.31 B-10,182.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ5.89 B-18,006.74%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ1.51 B-4,707.56%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.66 B-23,409.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
-ยฃ0.15 Billion 351.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.11 Billion 224.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ5.48 Billion 16,530.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ93.58 Million 184.40%๐Ÿ‡บ๐Ÿ‡ธ USA